ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0163

Trends in hospitalization and outcomes among patients admitted with Adult-onset Still’s disease in the United States: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE (2016-2022)

Mohammed Akram1, Muhammad Sohaib Asghar2, Woo Joo Lee2, Basmah Fayaz Yousuf3, Carmen Tormo Carillo4 and Savier Aleman Rama4, 1HCA Aventura, Aventura, FL, 2AdventHealth Sebring, Sebring, FL, 3SUNY Downstate Health Sciences University, New York, NY, 4HCA Florida Aventura Hospital, Aventura, FL

Meeting: ACR Convergence 2025

Keywords: Still's disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0145–0174) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Adult-onset Still’s Disease is a rare systemic autoinflammatory disorder characterized by spiking fever, arthralgia/arthritis, skin rash, and elevated inflammatory markers (ferritin). Estimated incidence ranges from 0.16 to 0.4 cases per 100,000 persons and is associated with significant morbidity during systemic flares requiring inpatient management. There is a lack of research related to hospitalization trends and outcomes of patients with this disease within the United States. Hence, we conducted this analysis from national databases to investigate the hospitalization trends of Adult Onset Still’s Disease pre and post COVID-19 pandemic era.

Methods: We used the National Inpatient Sample (NIS), a database that includes a subset of hospital discharges in 50 states, to identify patients with adult-onset Still’s disease who were admitted to the hospital due to any cause. Patients who were admitted in the years 2016 to 2022 (including the COVID-19 pandemic) were enrolled in the study. Adult-onset Still’s disease was defined based on the ICD-10 code M06.1. Patients were excluded based on age cut-off of < 15 years, and as well as juvenile rheumatoid arthritis identified as M08.2 were not included in the analysis. Discharge weights were applied to estimate national level representation. Adjusted hospital costs were reported for inflation in the year 2022 according to the U.S. Department of Labor inflation index for Medical Care Consumer Price Index (CPI) for cost-based analysis. Cochrane-armitage and Jonckheere-Terpstra test were applied as indicated to analyze the trends over the study period for in-hospital mortality rates, length of stay, inflation adjusted hospitalization costs respectively.

Results: There were a total of 1827 unweighted and 9135 weighted hospital discharges reported with a history of adult onset’s still disease on payer information through healthcare cost and utilization project (HCUP). Among these admissions over a span of 7 years within NIS databases, 40% were males and 60% females, 58% were white by ethnicity. In-hospital mortality rate was 2.3%, and the trend shows an increase amongst non-White population, especially after the COVID-19 pandemic (P=0.006). The most common primary reason of admission remains sepsis following adult-onset Still’s disease complications. Hospitalization costs and length of stay were found higher with male gender (p=0.001 & 0.006 respectively), and non-White population (p=0.001 & 0.005 respectively). Among non-White population, length of stay and hospitalization costs were found highest in Asians/Pacific Islanders population. Also, the mean age of these patients were comparatively higher than other races (50 vs 42 years), as opposed to White population with a mean age of 52 years (p< 0.001).

Conclusion: Sepsis was the most common primary reason for admission. Overall in-hospital mortality was low (2.3%) but increased significantly among non-White populations. Male gender and non-White race were associated with higher hospitalization costs and lengths of stay. Among subgroups, Asian/Pacific Islander patients had the highest resource use and were older at admission than other non-White groups.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: M. Akram: None; M. Asghar: None; W. Lee: None; B. Yousuf: None; C. Carillo: None; S. Rama: None.

To cite this abstract in AMA style:

Akram M, Asghar M, Lee W, Yousuf B, Carillo C, Rama S. Trends in hospitalization and outcomes among patients admitted with Adult-onset Still’s disease in the United States: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE (2016-2022) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/trends-in-hospitalization-and-outcomes-among-patients-admitted-with-adult-onset-stills-disease-in-the-united-states-insights-from-the-national-inpatient-sample-2016-2022/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-hospitalization-and-outcomes-among-patients-admitted-with-adult-onset-stills-disease-in-the-united-states-insights-from-the-national-inpatient-sample-2016-2022/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology